These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7044357)

  • 21. Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis.
    Lundberg R; Beilman GJ; Dunn TB; Pruett TL; Freeman ML; Ptacek PE; Berry KL; Robertson RP; Moran A; Bellin MD
    Pancreas; 2016 Apr; 45(4):565-71. PubMed ID: 26918872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes.
    Glaser B; Leibovich G; Nesher R; Hartling S; Binder C; Cerasi E
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):365-73. PubMed ID: 3293339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.
    Larsen S; Hilsted J; Tronier B; Worning H
    Metabolism; 1987 Oct; 36(10):964-7. PubMed ID: 3309547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
    Belovalova IM; Kniazeva AP; Starosel'tseva LK; Perelygina AA
    Probl Endokrinol (Mosk); 1988; 34(6):3-6. PubMed ID: 3070538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 29. Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.
    Madsbad S; Bottazzo GF; Cudworth AG; Dean B; Faber OK; Binder C
    Diabetologia; 1980 Jan; 18(1):45-7. PubMed ID: 6988264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of insulin autoantibodies with beta cell function at the time of diagnosis of diabetes mellitus.
    al-Attas OS
    Am J Med Sci; 1995 Oct; 310(4):138-42. PubMed ID: 7573116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parallel dysfunctions of pancreatic A, B and PP cells in insulin dependent diabetes.
    Nonaka K; Toyoshima H; Hanafusa T; Tarui S
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():127-33. PubMed ID: 7014203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
    Turner RC; Holman RR
    Diabetes; 1978; 27 Suppl 1():241-6. PubMed ID: 344115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functional activity of the insular apparatus of the pancreas in children with newly diagnosed diabetes mellitus].
    Shcherbacheva LN; Lobanova AM; Arbuzova MI
    Pediatriia; 1989; (11):10-4. PubMed ID: 2691976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
    Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
    Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.